{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:19:22Z","timestamp":1787764762239,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00206"],"award-info":[{"award-number":["PI19\/00206"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.isci.2023.108666","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T12:35:00Z","timestamp":1701952500000},"page":"108666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection"],"prefix":"10.1016","volume":"27","author":[{"given":"Julia","family":"Pe\u00f1a-Asensio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henar","family":"Calvo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Sanz-de-Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Gonz\u00e1lez-Praetorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Torralba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6383-848X","authenticated-orcid":false,"given":"Juan-Ram\u00f3n","family":"Larrubia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2023.108666_bib1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2023.108666_bib2","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1229620","article-title":"Progenitor and terminal subsets of CD8+ T\u00a0cells cooperate to contain chronic viral infection","volume":"338","author":"Paley","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.isci.2023.108666_bib3","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/bloodadvances.2018016279","article-title":"TCF1 expression marks self-renewing human CD8(+) T\u00a0cells","volume":"2","author":"Kratchmarov","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2023.108666_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav1730","article-title":"Modulation of asymmetric cell division as a mechanism to boost CD8(+) T\u00a0cell memory","volume":"4","author":"Borsa","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib5","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1126\/science.1139393","article-title":"Asymmetric T lymphocyte division in the initiation of adaptive immune responses","volume":"315","author":"Chang","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.isci.2023.108666_bib6","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.4049\/jimmunol.1200176","article-title":"Cutting edge: Asymmetric memory T\u00a0cell division in response to rechallenge","volume":"188","author":"Ciocca","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental Relationships of Four Exhausted CD8(+) T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2023.108666_bib8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.celrep.2016.10.032","article-title":"CD8(+) T Lymphocyte Self-Renewal during Effector Cell Determination","volume":"17","author":"Lin","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2023.108666_bib9","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.celrep.2016.11.065","article-title":"Anabolism-Associated Mitochondrial Stasis Driving Lymphocyte Differentiation over Self-Renewal","volume":"17","author":"Adams","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2023.108666_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.isci.2023.108666_bib11","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.celrep.2015.10.072","article-title":"Asymmetric PI3K Signaling Driving Developmental and Regenerative Cell Fate Bifurcation","volume":"13","author":"Lin","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2023.108666_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2023.108666_bib13","doi-asserted-by":"crossref","first-page":"14113","DOI":"10.1073\/pnas.1903520116","article-title":"Epigenetic signature of PD-1+ TCF1+ CD8 T\u00a0cells that act as resource cells during chronic viral infection and respond to PD-1 blockade","volume":"116","author":"Jadhav","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2023.108666_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)PD-1(+)CD8(+) T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2023.108666_bib15","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.isci.2023.108666_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhepr.2019.06.001","article-title":"HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection","volume":"1","author":"Ferrando-Martinez","year":"2019","journal-title":"JHEP Rep."},{"key":"10.1016\/j.isci.2023.108666_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nm.4275","article-title":"Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T\u00a0cells in chronic hepatitis B","volume":"23","author":"Fisicaro","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2023.108666_bib18","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.4049\/jimmunol.170.10.5018","article-title":"IL-15 promotes the survival of naive and memory phenotype CD8+ T\u00a0cells","volume":"170","author":"Berard","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/cmi.2010.44","article-title":"IL-15 increases the frequency of effector memory CD8+ T\u00a0cells in rhesus monkeys immunized with HIV vaccine","volume":"7","author":"Li","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4049\/jimmunol.0803355","article-title":"IL-15 regulates both quantitative and qualitative features of the memory CD8 T\u00a0cell pool","volume":"184","author":"Sandau","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.molimm.2019.11.011","article-title":"Control of memory CD8(+) T\u00a0cell longevity and effector functions by IL-15","volume":"117","author":"Nolz","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13578-016-0098-2","article-title":"IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia","volume":"6","author":"Xu","year":"2016","journal-title":"Cell Biosci."},{"key":"10.1016\/j.isci.2023.108666_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101307","article-title":"Common gamma chain cytokines and CD8 T\u00a0cells in cancer","volume":"42","author":"Shourian","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96219","article-title":"Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect","volume":"3","author":"Felices","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2023.108666_bib25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/2326-6066.CIR-18-0466","article-title":"IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype","volume":"7","author":"Alizadeh","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2023.108666_bib26","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2023.108666_bib27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2023.108666_bib28","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/apt.16850","article-title":"Model to predict on-treatment restoration of functional HBV-specific CD8(+) cell response foresees off-treatment HBV control in eAg-negative chronic hepatitis B","volume":"55","author":"Pe\u00f1a-Asensio","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.isci.2023.108666_bib29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.20171068","article-title":"4-1BB costimulation induces T\u00a0cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses","volume":"215","author":"Menk","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2023.108666_bib30","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/cmi.2016.02","article-title":"4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8(+) T\u00a0cell proliferation","volume":"14","author":"Choi","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib31","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.1100077","article-title":"4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T\u00a0cell responses during chronic viral infection","volume":"187","author":"Vezys","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2023.108666_bib33","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/hep.28438","article-title":"Discontinuation of oral antivirals in chronic hepatitis B: A systematic review","volume":"63","author":"Papatheodoridis","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2023.108666_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.17235\/reed.2022.9052\/2022","article-title":"Current challenges in the functional cure of HBe-Antigen-negative chronic hepatitis B","volume":"114","author":"Calvo S\u00e1nchez","year":"2022","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.isci.2023.108666_bib35","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","article-title":"The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8\u00a0T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis","volume":"45","author":"Gerlach","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2023.108666_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T\u00a0cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.isci.2023.108666_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15050","article-title":"TCF1(+) hepatitis C virus-specific CD8(+) T\u00a0cells are maintained after cessation of chronic antigen stimulation","volume":"8","author":"Wieland","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2023.108666_bib38","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1172\/JCI81261","article-title":"Inflammatory IL-15 is required for optimal memory T\u00a0cell responses","volume":"125","author":"Richer","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2023.108666_bib39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood-2005-12-4827","article-title":"Differential regulation of T-cell growth by IL-2 and IL-15","volume":"108","author":"Cornish","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.isci.2023.108666_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","article-title":"Mitochondrial respiratory capacity is a critical regulator of CD8+ T\u00a0cell memory development","volume":"36","author":"van der Windt","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2023.108666_bib41","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41423-020-0365-3","article-title":"Enforced PGC-1alpha expression promotes CD8 T\u00a0cell fitness, memory formation and antitumor immunity","volume":"18","author":"Dumauthioz","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib42","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8(+) T\u00a0cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib43","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","article-title":"Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8\u00a0T Cells in the Same Host","volume":"16","author":"Schurich","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2023.108666_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","article-title":"Memory CD8(+) T\u00a0cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development","volume":"41","author":"O'Sullivan","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2023.108666_bib45","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gutjnl-2018-316641","article-title":"Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T\u00a0cells in chronically HBV-infected patients with low viral load","volume":"68","author":"Schuch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.isci.2023.108666_bib46","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","article-title":"TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8\u00a0T Cell-Fate Decision","volume":"51","author":"Chen","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2023.108666_bib47","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/infdis\/jiaa269","article-title":"Combination rhIL-15 and Anti-PD-L1 (Avelumab) Enhances HIVGag-Specific CD8 T-Cell Function","volume":"222","author":"Goshu","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2023.108666_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41423-020-0427-6","article-title":"PD-1 blockade-unresponsive human tumor-infiltrating CD8(+) T\u00a0cells are marked by loss of CD28 expression and rescued by IL-15","volume":"18","author":"Kim","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2023.108666_bib49","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.ymthe.2020.07.018","article-title":"IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors","volume":"28","author":"Giuffrida","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2023.108666_bib50","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1158\/1078-0432.CCR-10-1966","article-title":"Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model","volume":"16","author":"Yu","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2023.108666_bib51","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S1470-2045(18)30148-7","article-title":"ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial","volume":"19","author":"Wrangle","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2023.108666_bib52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cellimm.2011.03.011","article-title":"Bim-mediated apoptosis and PD-1\/PD-L1 pathway impair reactivity of PD1(+)\/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection","volume":"269","author":"Larrubia","year":"2011","journal-title":"Cell. Immunol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223027438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223027438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:33:58Z","timestamp":1787762038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004223027438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2589004223027438"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2023.108666","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2023.108666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"108666"}}